UK

Unni Krishnan Karunakara

Director Director DIN 07241987
DIN 07241987 First appointment May 2016 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since May 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Unni Krishnan Karunakara

Data last updated:

Unni Krishnan Karunakara was a Director at Dndi Drugs For Neglected Diseases Initiative India Foundation (2016–2019). The company operates in Research & Development.

DIN 07241987
Primary Designation Director
Industry Research & Development
First Appointment 27 May 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 May 20162016₹20.1 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dndi Drugs For Neglected Diseases Initiative India Foundation
Premium access

Shareholding and investment profile for Unni Krishnan Karunakara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Unni Krishnan Karunakara

Unni Krishnan Karunakara was first appointed on 27 May 2016 as Director at Dndi Drugs For Neglected Diseases Initiative India Foundation.

Unni Krishnan Karunakara held 1 earlier board appointment: Dndi Drugs For Neglected Diseases Initiative India Foundation (Director, 27 May 2016 to 12 Jun 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available